Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARK2 pseudogene 12 (MARK2P12) is annotated as a pseudogene, meaning it is a non-functional DNA segment that is homologous to the coding gene for microtubule affinity-regulating kinase 2 (MARK2), but it does not encode a functional protein[3][5]. Pseudogenes like MARK2P12 typically arise from gene duplication or retrotransposition events and accumulate mutations that prevent normal protein translation. While some pseudogenes have regulatory roles through their RNA transcripts by acting as microRNA decoys or affecting the stability of related mRNAs[4][6], there is currently no specific evidence that MARK2P12 has any known biological or disease role, nor involvement in drug targeting or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARK2 pseudogene 12 (MARK2P12).